Search results

• Marginal zone lymphoma
  [[Category:Oncology]]
  103 bytes (9 words) - 01:17, 4 July 2020
• MATRix
  [[Category:Oncology]]
  220 bytes (20 words) - 19:02, 5 November 2024
• Stiff person syndrome
  [[Category:Oncology]]
  139 bytes (13 words) - 16:44, 20 August 2021
• Renal cell carcinoma
  [[Category:Oncology]]
  204 bytes (23 words) - 16:42, 5 April 2022
• VIP regimen
  [[Category:Oncology]]
  204 bytes (23 words) - 17:36, 5 September 2024
• Lenalidomide
  [[Category:Oncology]]
  220 bytes (21 words) - 14:57, 9 February 2023
• ECOG
  Eastern Cooperative Oncology Group (ECOG) [[Category:Oncology]]
  739 bytes (110 words) - 01:17, 4 July 2020
• CR:DOI:01b077a5118d85e815c2fa27293262e3
  |journal=Journal of Clinical Oncology |publisher=American Society of Clinical Oncology (ASCO)
  895 bytes (116 words) - 14:13, 23 September 2024
• AL-4
  [[Category:Oncology]]
  396 bytes (33 words) - 14:11, 31 March 2025
• Plasma cell granuloma
  [[Category:Oncology]]
  266 bytes (36 words) - 14:49, 14 September 2022
• Everolimus
  [[Category:Oncology]]
  302 bytes (34 words) - 19:24, 17 September 2024
• Hepatocellular carcinoma
  [[Category:Oncology]]
  129 bytes (13 words) - 18:14, 13 October 2020
• Thalidomide
  [[Category:Oncology]]
  249 bytes (31 words) - 17:06, 14 November 2022
• Mogamulizumab
  [[Category:Oncology]]
  344 bytes (41 words) - 18:55, 24 November 2023
• Bortezomib
  [[Category:Oncology]]
  400 bytes (46 words) - 17:05, 14 November 2022
• Meningioma
  [[Category:Oncology]]
  323 bytes (33 words) - 13:56, 16 July 2020
• Ibrutinib
  [[Category:Oncology]]
  408 bytes (47 words) - 17:49, 5 July 2024
• Myeloproliferative neoplasm
  [[Category:Oncology]]
  372 bytes (37 words) - 16:59, 23 February 2024
• Abemaciclib
  [[Category:Oncology]]
  410 bytes (46 words) - 16:27, 17 September 2024
• Lenvatinib
  [[Category:Oncology]]
  393 bytes (48 words) - 19:27, 17 September 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)